In patients with CKD, an independent association has been demonstrated between elevated FGF23 and increased inflammatory markers, including IL-6, CRP, and tumor necrosis factor-α (TNF-α) [4, 5]. The gene discussed is FGF23; the disease is chronic kidney disease.